VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,793,000 | +19.3% | 124,982 | -0.4% | 1.86% | +24.0% |
| Q4 2021 | $4,019,000 | +11.5% | 125,464 | +2.5% | 1.50% | +1.6% |
| Q3 2021 | $3,606,000 | -11.3% | 122,345 | +2.2% | 1.48% | -11.1% |
| Q2 2021 | $4,066,000 | -5.6% | 119,662 | -18.7% | 1.66% | -39.1% |
| Q4 2019 | $4,309,000 | +4.2% | 147,153 | -1.9% | 2.73% | -9.8% |
| Q3 2019 | $4,135,000 | +11.2% | 149,942 | -0.8% | 3.02% | +7.5% |
| Q2 2019 | $3,717,000 | – | 151,202 | – | 2.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |